Found: 23
Select item for more details and to access through your institution.
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1536-9
- By:
- Publication type:
- Article
Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1200-1
- By:
- Publication type:
- Article
Carbamazepine-induced aseptic meningitis.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Frailty and Cause-Specific Hospitalizations in Community-Dwelling Older Men.
- Published in:
- Journal of Nutrition, Health & Aging, 2020, v. 24, n. 6, p. 563, doi. 10.1007/s12603-020-1352-1
- By:
- Publication type:
- Article
The histone database: A comprehensive resource for histones and histone fold-containing proteins.
- Published in:
- Proteins, 2006, v. 62, n. 4, p. 838, doi. 10.1002/prot.20814
- By:
- Publication type:
- Article
Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00150-y
- By:
- Publication type:
- Article
The Homeodomain Resource: 2003 update.
- Published in:
- Nucleic Acids Research, 2003, v. 31, n. 1, p. 304, doi. 10.1093/nar/gkg118
- By:
- Publication type:
- Article
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in phase III clinical trials.
- Published in:
- Arthritis Care & Research, 2013, v. 65, n. 2, p. 309, doi. 10.1002/acr.21788
- By:
- Publication type:
- Article
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
- Published in:
- Rheumatology, 2013, v. 52, n. 10, p. 1845, doi. 10.1093/rheumatology/ket233
- By:
- Publication type:
- Article
Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE).
- Published in:
- Rheumatology, 2013, v. 52, n. 2, p. 321, doi. 10.1093/rheumatology/kes251
- By:
- Publication type:
- Article
Joint longitudinal model development: application to exposure-response modeling of ACR and DAS scores in rheumatoid arthritis patients treated with sirukumab.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 5, p. 679, doi. 10.1007/s10928-018-9598-5
- By:
- Publication type:
- Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2174, doi. 10.1002/art.39722
- By:
- Publication type:
- Article
Exposure‐Response Modeling Analyses for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin 6, in Patients With Moderately to Severely Active Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 11, p. 1501, doi. 10.1002/jcph.1272
- By:
- Publication type:
- Article
Confirmatory Population Pharmacokinetic Analysis for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin‐6, in Patients With Moderately to Severely Active Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 7, p. 939, doi. 10.1002/jcph.1101
- By:
- Publication type:
- Article
Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T).
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 2, p. 306, doi. 10.1080/14397595.2018.1452345
- By:
- Publication type:
- Article
Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 study.
- Published in:
- Modern Rheumatology, 2018, v. 28, n. 6, p. 941, doi. 10.1080/14397595.2018.1428929
- By:
- Publication type:
- Article
Sirukumab: A Potential Treatment for Mood Disorders?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Autoregressive modeling and diagnostics for qPCR amplification.
- Published in:
- Bioinformatics, 2020, v. 36, n. 22/23, p. 5386, doi. 10.1093/bioinformatics/btaa1000
- By:
- Publication type:
- Article